EP Patent

EP2144599A2 — Sustained release pellets comprising wax-like material

Assigned to Farnam Companies Inc · Expires 2010-01-20 · 16y expired

What this patent protects

Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent are provided. Oral dosage forms comprising said pellets and methods for preparing and using such pellets and dosage forms are also provided.

USPTO Abstract

Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent are provided. Oral dosage forms comprising said pellets and methods for preparing and using such pellets and dosage forms are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2144599A2
Jurisdiction
EP
Classification
—
Expires
2010-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Farnam Companies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.